WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

KR

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

KR

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

KR

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

KR

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

WMT

117.81

+0.01%↑

COST

983.41

+0.83%↑

TGT

108.01

+1.35%↑

KR

64.24

+2.62%↑

DG.US

146.86

+1.62%↑

Search

Afya Ltd (Class A)

Closed

SectorConsumer defensive

14.58 2.24

Overview

Share price change

24h

Current

Min

14.51

Max

14.63

Key metrics

By Trading Economics

Income

-13M

181M

Sales

9.1M

929M

P/E

Sector Avg

9.349

29.272

Dividend yield

1.67

Profit margin

19.455

EBITDA

-28M

397M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+29.01% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.67%

3.56%

Next Earnings

12 Mar 2026

Market Stats

By TradingEconomics

Market Cap

-50M

1.3B

Previous open

12.34

Previous close

14.58

News Sentiment

By Acuity

100%

0%

129 / 133 Consumer defensive

Technical Score

By Trading Central

Confidence

Bullish Evidence

Afya Ltd (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

23 Jan 2026, 18:41 UTC

Earnings

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

24 Jan 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

24 Jan 2026, 09:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

24 Jan 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 Jan 2026, 09:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

24 Jan 2026, 06:18 UTC

Acquisitions, Mergers, Takeovers

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 Jan 2026, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

23 Jan 2026, 22:30 UTC

Market Talk

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 Jan 2026, 22:03 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 Jan 2026, 21:52 UTC

Earnings
Acquisitions, Mergers, Takeovers

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 Jan 2026, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

23 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 Jan 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

23 Jan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 Jan 2026, 21:39 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 Jan 2026, 21:15 UTC

Acquisitions, Mergers, Takeovers

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 Jan 2026, 21:12 UTC

Earnings

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 Jan 2026, 20:31 UTC

Earnings

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 Jan 2026, 20:12 UTC

Market Talk

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 Jan 2026, 20:07 UTC

Market Talk

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 Jan 2026, 19:36 UTC

Market Talk

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 Jan 2026, 19:30 UTC

Market Talk
Earnings

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 Jan 2026, 19:18 UTC

Market Talk

Gold and Silver Step Up to More Records -- Market Talk

23 Jan 2026, 19:15 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

23 Jan 2026, 18:53 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

23 Jan 2026, 18:21 UTC

Earnings

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

23 Jan 2026, 18:19 UTC

Market Talk

Intel Seen as Increasingly Confident on Demand -- Market Talk

23 Jan 2026, 17:59 UTC

Earnings

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

23 Jan 2026, 17:57 UTC

Market Talk

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

23 Jan 2026, 17:57 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Afya Ltd (Class A) Forecast

Price Target

By TipRanks

29.01% upside

12 Months Forecast

Average 18.9 USD  29.01%

High 22 USD

Low 16 USD

Based on 5 Wall Street analysts offering 12 month price targets forAfya Ltd (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

18.968 / 19.56Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat